Innovation Pharmaceuticals Inc (IPIX)

[frrol]

There are usually dropouts, and bigger sample is better than smaller. In larger advanced trials (2B and 3) biotechs will establish a floor (ie minimum) sample target that meets what they and the FDA (and possible BP partners) would deem "adequate", with room for additional patients as contingency.